Skip to main content

Table 2 Depressive symptoms (PHQ-9) by the type of ovarian function suppression in patients with breast cancer

From: Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists

 

Ovarian Ablation (OA) n, (%)

Ovarian function suppression

GnRH agonist (GnRHa) n, (%)

t or χ2 value

P value

Total

174

389

  

PHQ-9 scores Median(IQR)

13 (8.0-17.0)

11 (7.0-16.0)

  

PHQ-9 scores Range

1-24

0-25

  

PHQ-9 scores Mean (SD)

12.8 ± 5.8

11.4 ± 5.7

1.892

0.059

PHQ-9 scores subgroups

 None or mild (0-7), n(%)

40 (23.0)

101 (26.0)

  

 Moderate (8-14), n(%)

63 (36.2)

167 (42.9)

  

 Major (15-19), n(%)

49 (28.2)

87 (22.4)

  

 Severe (20-27), n(%)

22 (12.6)

34 (8.7)

  

 Major Depression

(PHQ≥15), n(%)

71

(40.8)

121

(31.1)

5.033

0.025

 Suicidal ideation, n(%)

15 (8.6)

30 (7.7)

0.135

0.713

  1. PHQ-9 Patient Health Questionnaire - 9 items, SE Standard errors, IQR Interquartile range (25th, 75th percentiles).